# Optimal Analgesia in Acute Gastroenteritis

> **NCT02711241** · PHASE3 · TERMINATED · sponsor: **Hadassah Medical Organization** · enrollment: 15 (actual)

## Conditions studied

- Gastroenteritis

## Interventions

- **DRUG:** Dipyrone
- **DRUG:** Papaverine

## Key facts

- **NCT ID:** NCT02711241
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Not enough patients
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02711241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02711241, "Optimal Analgesia in Acute Gastroenteritis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02711241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*